Vladimir Tolmachev - Search Results

Year	Number of Results
2002	5
2003	6
2004	9
2005	9
2006	8
2007	19
2008	7
2009	10
2010	17
2011	22
2012	15
2013	12
2014	17
2015	11
2016	17
2017	11
2018	19
2019	23
2020	19
2021	15

1

Pretargeted Imaging and Therapy.

Altai M, Membreno R, Cook B, Tolmachev V, Zeglis BM. Altai M, et al. Among authors: tolmachev v. J Nucl Med. 2017 Oct;58(10):1553-1559. doi: 10.2967/jnumed.117.189944. Epub 2017 Jul 7. J Nucl Med. 2017. PMID: 28687600 Free PMC article. Review.

2

Affibody Molecules as Targeting Vectors for PET Imaging.

Tolmachev V, Orlova A. Tolmachev V, et al. Cancers (Basel). 2020 Mar 11;12(3):651. doi: 10.3390/cancers12030651. Cancers (Basel). 2020. PMID: 32168760 Free PMC article. Review.

3

Preparation of Conjugates for Affibody-Based PNA-Mediated Pretargeting.

Altai M, Vorobyeva A, Tolmachev V, Karlström AE, Westerlund K. Altai M, et al. Among authors: tolmachev v. Methods Mol Biol. 2020;2105:283-304. doi: 10.1007/978-1-0716-0243-0_18. Methods Mol Biol. 2020. PMID: 32088878

4

Imaging using radiolabelled targeted proteins: radioimmunodetection and beyond.

Garousi J, Orlova A, Frejd FY, Tolmachev V. Garousi J, et al. Among authors: tolmachev v. EJNMMI Radiopharm Chem. 2020 Jun 23;5(1):16. doi: 10.1186/s41181-020-00094-w. EJNMMI Radiopharm Chem. 2020. PMID: 32577943 Free PMC article. Review.

5

Basic and practical concepts of radiopharmaceutical purification methods.

Molavipordanjani S, Tolmachev V, Hosseinimehr SJ. Molavipordanjani S, et al. Among authors: tolmachev v. Drug Discov Today. 2019 Jan;24(1):315-324. doi: 10.1016/j.drudis.2018.09.018. Epub 2018 Sep 29. Drug Discov Today. 2019. PMID: 30278224 Review.

6

Engineering of affibody molecules for therapy and diagnostics.

Feldwisch J, Tolmachev V. Feldwisch J, et al. Among authors: tolmachev v. Methods Mol Biol. 2012;899:103-26. doi: 10.1007/978-1-61779-921-1_7. Methods Mol Biol. 2012. PMID: 22735949 Review.

7

Radiolabeled probes targeting tyrosine-kinase receptors for personalized medicine.

Altai M, Orlova A, Tolmachev V. Altai M, et al. Among authors: tolmachev v. Curr Pharm Des. 2014;20(14):2275-92. doi: 10.2174/13816128113196660667. Curr Pharm Des. 2014. PMID: 24025099 Review.

8

Radiolabeled GRPR Antagonists for Imaging of Disseminated Prostate Cancer - Influence of Labeling Chemistry on Targeting Properties.

Mitran B, Tolmachev V, Orlova A. Mitran B, et al. Among authors: tolmachev v. Curr Med Chem. 2020;27(41):7090-7111. doi: 10.2174/0929867327666200312114902. Curr Med Chem. 2020. PMID: 32164503 Review.

9

Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1.

Vorobyeva A, Konovalova E, Xu T, Schulga A, Altai M, Garousi J, Rinne SS, Orlova A, Tolmachev V, Deyev S. Vorobyeva A, et al. Among authors: tolmachev v. Int J Mol Sci. 2020 May 7;21(9):3310. doi: 10.3390/ijms21093310. Int J Mol Sci. 2020. PMID: 32392820 Free PMC article.

10

Evaluation of an antibody-PNA conjugate as a clearing agent for antibody-based PNA-mediated radionuclide pretargeting.

Myrhammar A, Vorobyeva A, Westerlund K, Yoneoka S, Orlova A, Tsukahara T, Tolmachev V, Karlström AE, Altai M. Myrhammar A, et al. Among authors: tolmachev v. Sci Rep. 2020 Nov 27;10(1):20777. doi: 10.1038/s41598-020-77523-y. Sci Rep. 2020. PMID: 33247180 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results